Atlas Trials

Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)

Clinical trial NCT04140227 · COMPLETED

Trial details

NCT number
NCT04140227
Sponsor
Bausch & Lomb Incorporated
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dry Eye Disease (DED)
Start date
2020-09-24
Primary completion
2022-01-05
Enrollment
256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.